Texas A&M Develops Cheaper Glucose Sensing Material

Researchers found a sensing material costing about one-tenth as much as a common alternative performs comparably in an experimental injectable glucose sensor.

Updated on Nov. 3, 2026 in Diabetes

Vector editorial illustration of a clear glass vial holding a translucent amber droplet on a gray surface, evoking a lower-cost glucose sensing material. — Texas A&M University researchers found a sensing material costing about one-tenth as much as a common alternative performs comparably in an experimental injectable glucose sensor. AI Illustration. Upload story photo >

Live Poll

Do you think cheaper glucose monitors would make a real difference for people you know?

Texas A&M University researchers identified a lower-cost sensing material for an experimental injectable glucose sensor. The material performed comparably to a commonly used alternative that costs roughly ten times more, according to a study published in ACS Measurement Science AU.

Why it matters

Continuous glucose monitors remain out of reach for some patients because of cost, so a cheaper sensing component could broaden access if the technology advances. The work remains at the proof-of-concept stage in College Station and elsewhere.

The lower-cost material, β-mannopentaose, is significantly less expensive than the α-mannopentaose alternative while delivering comparable sensing performance in artificial interstitial fluid. Testing is limited to laboratory conditions, and clinical performance in patients has not been evaluated.

The players

Texas A&M University

A public research university in College Station, Texas, whose researchers conducted the glucose sensing study.

The details

The platform uses near-infrared fluorescence and avoids enzymes; as glucose rises, it competes with a fluorescent sugar compound for binding sites on concanavalin A, changing the signal. The sensing chemistry was incorporated into a small injectable hydrogel designed for the experimental sensor.

November 3, 2026: Texas A&M glucose sensor component research publicized

Health Landscape

Continuous glucose monitors have become a major advance over fingerstick testing for people with diabetes, but their cost keeps them out of reach for some patients. This injectable sensor research explores whether cheaper sensing chemistry could help extend that technology more broadly.

For people who rely on glucose monitoring, lower sensor costs could eventually mean more affordable options for tracking blood sugar. The technology is not yet available, and no timeline for patient use has been established.

The takeaway

Cost remains a barrier to continuous glucose monitoring, and this research shows one path toward cheaper components. Readers should follow clinical development before expecting changes to available devices.